PK/PD Modeling of a Novel Pleuromutilin Derivative Pleuro2–4 against Mycoplasma gallisepticum in Chicks
Journal of Agricultural and Food Chemistry · 2026
DOI: 10.1021/acs.jafc.6c08587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2026. Verfasst von Feifei Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricu…. Hauptthemen laut MEDLINE: Mycoplasma gallisepticum, Mycoplasma Infections, Diterpenes, Poultry Diseases. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Mycoplasma gallisepticum is a major causative agent of chronic respiratory disease in poultry, and effective antimicrobial therapy remains essential for disease control. In this study, the antimycoplasmal activity, pharmacokinetics, therapeutic efficacy, and pharmacokinetic/pharmacodynamic (PK/PD) model of Pleuro2–4, a novel pleuromutilin candidate, were systematically evaluated against M. gallisepticum. Pleuro2–4 exhibited potent in vitro activity (MIC = 0.0078 μg/mL) and concentration-dependent killing. Following oral administration in chicks, Pleuro2–4 was rapidly converted to its active metabolite and displayed rapid absorption and sustained exposure in lung tissue. In an M. gallisepticum infection model, Pleuro2–4 alleviated respiratory lesions, reduced mycoplasmal loads, and suppressed inflammatory responses. PK/PD integration using an inhibitory sigmoid Emax model identified AUC0–24h/MIC as the PK/PD index for dose optimization. The bactericidal target was 3372.82 h, corresponding to a recommended oral dosage of 44.99 mg/kg once daily for three consecutive days. These findings support Pleuro2–4 as a promising candidate for avian mycoplasmosis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou510642, China.
- National Laboratory of Safety Evaluation (Environmental Assessment) of Veterinary Drugs, South China Agricultural University, Guangzhou510642, China.
- National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou510642, China.
ORCID-Profile: Dongping Zeng, Youzhi Tang, Zhenling Zeng
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Zhao, F., Zhu, Y., Zhang, T., Wei, W., Huang, H., Zeng, D., Xiong, W., Tang, Y., & Zeng, Z. (2026). PK/PD Modeling of a Novel Pleuromutilin Derivative Pleuro2–4 against Mycoplasma gallisepticum in Chicks. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.6c08587
Vancouver
Zhao F, Zhu Y, Zhang T, Wei W, Huang H, Zeng D, et al. PK/PD Modeling of a Novel Pleuromutilin Derivative Pleuro2–4 against Mycoplasma gallisepticum in Chicks. Journal of Agricultural and Food Chemistry. 2026. doi:10.1021/acs.jafc.6c08587
BibTeX
@article{Zhao2026,
author = {Zhao, Feifei and Zhu, Yizhen and Zhang, Tingting and Wei, Wei and Huang, Honghao and Zeng, Dongping and Xiong, Wenguang and Tang, Youzhi and Zeng, Zhenling},
title = {PK/PD Modeling of a Novel Pleuromutilin Derivative Pleuro2–4 against Mycoplasma gallisepticum in Chicks},
journal = {Journal of Agricultural and Food Chemistry},
year = {2026},
doi = {10.1021/acs.jafc.6c08587}
}
EUVIMED